To hear about similar clinical trials, please enter your email below
Trial Title:
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
NCT ID:
NCT06079723
Condition:
Medullary Thyroid Cancer
Conditions: Official terms:
Thyroid Neoplasms
Carcinoma, Neuroendocrine
Thyroid Diseases
Conditions: Keywords:
Medullary Thyroid Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal
role in evaluating the safety and effectiveness of novel treatments for this condition.
These trials serve as essential tools to determine whether new medications surpass
conventional therapies, providing substantial evidence to endorse their broader adoption.
The primary objective is to meticulously examine trial completion rates and voluntary
withdrawals within this specific patient group. By actively participating in this
observational study plays a critical role in pushing medical knowledge forward and
advancing care for individuals suffering from the medullary thyroid cancer.
Criteria for eligibility:
Study pop:
Medullary thyroid cancer patients who are actively considering enrolling in an
observational clinical study for said condition, but have not yet completed enrollment
and randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Confirmed diagnosis of medullary thyroid cancer
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- No serious medical or psychiatric illness likely to interfere with participation in
this clinical study.
Exclusion Criteria:
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of
the study
- Any serious and/or unstable pre-existing medical disorders
- Patients who are currently receiving any other investigational drug.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
November 2024
Completion date:
November 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06079723
